Cian Healthcare — 360° view

Cian Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹12 crore and a net loss of ₹1.00 crore for the September 2026 quarter.

Cian Healthcare (BSE: CHCL) closed at ₹44.10 on 20 Nov 2026. Its market capitalisation is ₹110 crore.

Share price
₹44.10 (20 Nov 2026)
Market cap
₹110 Cr (20 Nov 2026)
Revenue
₹12 Cr (September 2026 quarter)
Net profit
₹-1 Cr (September 2026 quarter)
ROCE
-15.1% (FY26)
ROE
-49.2% (FY26)
Book value
₹3.42 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹44.10 / ₹7.50 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: CHCL

Cian Healthcare Ltd is a BSE-SME listed pharmaceutical-formulations manufacturer with own /franchise brands, third-party manufacturing, institutional/government supply and exports. It makes tablets, capsules, soft-gels, liquid orals, ointments/creams, sachets and cosmetics across gynaecology, haematinic, cardio-diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins and nutrients. The company exited CIRP under new promoter control in FY26

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.